close

Agreements

Date: 0000-00-00

Type of information: Opening of new premises

Compound: new European Head Quarters in Geneva

Company: Santen Pharmaceutical (Japan)

Therapeutic area: Ophtalmological diseases

Type agreement:

opening of new premises

Action mechanism:

Disease:

Details:

* On September 2, 2015, Santen Pharmaceutical has officially inaugurated its new European Head Quarters in Geneva, Switzerland. The company has been present in Europe since the 1990s, and today employs over 600 professionals across the continent. The new European HQ in Geneva, Switzerland, will lead the growing commercial network, manufacturing and R&D activities. Mr Akira Kurokawa, President and CEO of Santen, said: “Our ambition for 2020 is to become a specialised company with a global presence and overseas sales to represent 40% -50% of our revenues. This new European HQ is a key element in that strategy. Switzerland and Geneva in particular offers an outstanding location from which to expand our commercial footprint, and to benefit from the life-science expertise and networks established here.”

Financial terms:

Latest news:

Is general: Yes